Ifosfamide Injection, Powder, For Solution
Product Images NDC 10019-929

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ifosfamide (NDC 10019-929). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ifosfamide Novaplus Structural Formula (Image 01)

Chemical structure diagram of ifosfamide showing its molecular framework with phosphorus, oxygen, nitrogen atoms, and chloroethyl groups as part of the compound.*

FDA Label Image

Novaplus Logo (Image 02)

FDA Label Image

Representative Ifosfamide Novaplus Container Label 10019-927-20 (Image 03)

Label for Ifosfamide Injection 1 g/vial single dose vial, injection powder for solution, for intravenous use. Manufactured by Baxter Healthcare Corporation, this label includes preparation instructions to add 20 mL sterile water or bacteriostatic water for injection to reconstitute 50 mg per mL concentration, storage conditions, and a notice to read the package insert for more information.*

FDA Label Image

Representative Ifosfamide Novaplus Carton Label 10019-927-01 (Image 04)

Packaging label for Ifosfamide Injection 1 g per vial, a powder for solution for intravenous use. The label shows the brand name Ifosfamide, strength, Rx only status, and manufacturer Baxter Healthcare Corporation in Deerfield, IL. It includes storage instructions and vial preparation details on the side panel.*

FDA Label Image

Representative Ifosfamide Novaplus Container Label 10019-929-60 (Image 05)

The label for Ifosfamide for Injection, 3 g, single-dose vial by Baxter Healthcare Company. It is an intravenous powder for solution. Instructions indicate adding 60 mL sterile water or bacteriostatic water to reconstitute the dose. Storage recommendations specify controlled room temperature between 20°C and 25°C (68°F to 77°F) with protection from temperatures above 30°C (86°F).*

FDA Label Image

Representative Ifosfamide Novaplus Carton Label 10019-929-03 (Image 06)

Packaging label for Ifosfamide for Injection 3 g/vial, an intravenous powder for solution by Baxter Healthcare Corporation. The label shows single-dose vial usage, storage instructions, and warnings. It includes the NDC 10019-929-03 and manufacturer details in Deerfield, IL, USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.